Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,000
Closed -$443K 639
2025
Q3
$443K Hold
3,000
0.08% 106
2025
Q2
$388K Hold
3,000
0.08% 117
2025
Q1
$358K Hold
3,000
0.08% 122
2024
Q4
$348K Hold
3,000
0.07% 117
2024
Q3
$405K Hold
3,000
0.09% 105
2024
Q2
$407K Hold
3,000
0.1% 97
2024
Q1
$388K Hold
3,000
0.1% 99
2023
Q4
$343K Buy
3,000
+1,109
+59% +$111K 0.1% 103
2023
Q3
$172K Buy
+1,891
New +$195K 0.07% 87

Other funds holding XYL

Arlington Trust's XYL Position: Q4 2025 in Review

Arlington Trust sold out of Xylem (XYL) in Q4 2025, closing a stake of 3,000 shares — an estimated $443K sold.

Arlington Trust first reported a position in XYL in Q3 2023 and held it in 9 quarters. The position peaked at $443K in Q3 2025. 1,133 funds tracked by Wall St. Rank hold XYL as of Q4 2025.

  • Arlington Trust reported no remaining Xylem position as of Q4 2025 after selling out during the quarter.
  • Arlington Trust sold 3,000 Xylem shares in Q4 2025, an estimated $443K.
  • Arlington Trust first reported a position in Xylem in Q3 2023 and held it in 9 quarters.
  • Arlington Trust's Xylem position peaked at $443K in Q3 2025.
  • 1,133 funds tracked by Wall St. Rank held Xylem as of Q4 2025.

Based on Arlington Trust's 13F filing for Q4 2025, filed 30 Jan 2026.